MERIDIAN BIOSCIENCE INC Quarterly Interest Expense in USD from Q1 2016 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Meridian Bioscience Inc quarterly/annual Interest Expense history and growth rate from Q1 2016 to Q4 2022.
  • Meridian Bioscience Inc Interest Expense for the quarter ending December 31, 2022 was $148K, a 60.2% decline year-over-year.
  • Meridian Bioscience Inc Interest Expense for the twelve months ending December 31, 2022 was $965K, a 43.8% decline year-over-year.
  • Meridian Bioscience Inc annual Interest Expense for 2022 was $1.19M, a 36.7% decline from 2021.
  • Meridian Bioscience Inc annual Interest Expense for 2021 was $1.88M, a 28.6% decline from 2020.
  • Meridian Bioscience Inc annual Interest Expense for 2020 was $2.63M, a 35.3% increase from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 $965K $148K -$224K -60.2% Oct 1, 2022 Dec 31, 2022 10-Q 2023-02-09
Q3 2022 $1.19M $220K -$208K -48.6% Jul 1, 2022 Sep 30, 2022 10-K 2022-11-22
Q2 2022 $1.4M $256K -$188K -42.3% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $1.59M $341K -$131K -27.8% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $1.72M $372K -$162K -30.3% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-09
Q3 2021 $1.88M $428K -$202K -32.1% Jul 1, 2021 Sep 30, 2021 10-K 2022-11-22
Q2 2021 $2.08M $444K -$259K -36.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $2.34M $472K -$60K -11.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $2.4M $534K -$233K -30.4% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-04
Q3 2020 $2.63M $630K -$157K -19.9% Jul 1, 2020 Sep 30, 2020 10-K 2022-11-22
Q2 2020 $2.79M $703K +$255K +56.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $2.53M $532K +$185K +53.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $2.35M $767K +$404K +111% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-05
Q3 2019 $1.95M $787K +$416K +112% Jul 1, 2019 Sep 30, 2019 10-K 2021-11-23
Q2 2019 $1.53M $448K +$73K +19.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $1.46M $347K -$32K -8.44% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $1.49M $363K -$32K -8.1% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-07
Q3 2018 $1.52M $371K -$33K -8.17% Jul 1, 2018 Sep 30, 2018 10-K 2020-11-23
Q2 2018 $1.55M $375K -$32K -7.86% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $1.59M $379K -$29K -7.11% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $1.61M $395K -$28K -6.62% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-11
Q3 2017 $1.64M $404K Jul 1, 2017 Sep 30, 2017 10-K 2019-11-26
Q2 2017 $407K -$20K -4.68% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $408K +$365K +849% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $423K Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-07
Q2 2016 $427K Mar 25, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $43K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.